Sugarloaf Wealth Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Sugarloaf Wealth Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,325	Closed	-$5.72K	–	705
2023 Q3	$5.72K	Sell	3,325 -2,648	-44%	-$4.7K	﹤0.01%	521
2023 Q2	$11.6K	Buy	5,973 +245	+4%	+$574	﹤0.01%	458
2023 Q1	$15.9K	Hold	5,728	–	–	﹤0.01%	419
2022 Q4	$19.8K	Buy	5,728 +1,677	+41%	+$4.79K	0.01%	407
2022 Q3	$11K	Sell	4,051 -1,760	-30%	-$5.6K	﹤0.01%	517
2022 Q2	$14K	Buy	+5,811	New	+$15.3K	﹤0.01%	477

Other funds holding GRTS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Sugarloaf Wealth Management's GRTS Position: Q4 2023 in Review

Sugarloaf Wealth Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2023, closing a stake of 3,325 shares — an estimated $5.72K sold.

Sugarloaf Wealth Management first reported a position in GRTS in Q2 2022 and held it in 6 quarters. The position peaked at $19.8K in Q4 2022. 88 funds tracked by Wall St. Rank hold GRTS as of Q4 2023.

Sugarloaf Wealth Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Sugarloaf Wealth Management sold 3,325 Gritstone bio, Inc. Common Stock shares in Q4 2023, an estimated $5.72K.
Sugarloaf Wealth Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Sugarloaf Wealth Management's Gritstone bio, Inc. Common Stock position peaked at $19.8K in Q4 2022.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2023.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2023, filed 10 Jan 2024.